SLC6A3 and Parkinson disease: In the 10th injection, down-regulated genes were significantly enriched in terms of “Parkinson’s disease” and “Dopaminergic synapse” (such as Th, Drd2, Slc6a3, and Slc18a2) (Fig. 5c).